MOH — authorised 17 November 1995
- Marketing authorisation holder: VIIV HLTHCARE
- Status: likely_approved
MOH authorised Epivir on 17 November 1995
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 17 November 1995.
VIIV HLTHCARE holds the Israeli marketing authorisation.